7/20/2017 Cost Analysis Project Meeting

Extract Evidence for:
1. Clinical Effectiveness for both FEIBA and rFVIIa
	i. Using Borg and Baudo
	ii. Cycle length and Time Horizon 1 day and 5 days max

2. Utilities
	i. From HRQoL studies and EQ-5D measures available from MedLine/PUBMED
	
3. Cost
	i. From UAB and also data available from BIA models and other CEA models
	
4. Fill in the Trace and code MACRO for MCMC simulation

5. CEAC curve and INC CE plane and Final Results for Deterministic and Prob ICER

6. Write Methods and Results for Manuscript